{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T02:04:15Z","timestamp":1794621855769,"version":"4.9.1"},"reference-count":88,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,12,30]],"date-time":"2019-12-30T00:00:00Z","timestamp":1577664000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,12,30]],"date-time":"2019-12-30T00:00:00Z","timestamp":1577664000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Ministry of Economy and Competitiveness | Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["CB16\/11\/00479"],"award-info":[{"award-number":["CB16\/11\/00479"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Ministry of Economy and Competitiveness | Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["CB16\/11\/00358"],"award-info":[{"award-number":["CB16\/11\/00358"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Despite many cardioprotective interventions have shown to protect the heart against ischemia\/reperfusion injury in the experimental setting, only few of them have succeeded in translating their findings into positive proof-of-concept clinical trials. Controversial and inconsistent experimental and clinical evidence supports the urgency of a disruptive paradigm shift for testing cardioprotective therapies. There is a need to evaluate experimental reproducibility before stepping into the clinical arena. The CIBERCV (acronym for Spanish network-center for cardiovascular biomedical research) has set up the \u201cCardioprotection Large Animal Platform\u201d (CIBER-CLAP) to perform experimental studies testing the efficacy and reproducibility of promising cardioprotective interventions based on a pre-specified design and protocols, randomization, blinding assessment and other robust methodological features. Our first randomized, control-group, open-label blinded endpoint experimental trial assessing local ischemic preconditioning (IPC) in a pig model of acute myocardial infarction (n\u2009=\u200987) will be carried out in three separate sets of experiments performed in parallel by three laboratories. Each set aims to assess: (A) CMR-based outcomes; (B) histopathological-based outcomes; and (C) protein-based outcomes. Three core labs will assess outcomes in a blinded fashion (CMR imaging, histopathology and proteomics) and 2 methodological core labs will conduct the randomization and statistical analysis.<\/jats:p>","DOI":"10.1038\/s41598-019-56613-6","type":"journal-article","created":{"date-parts":[[2019,12,30]],"date-time":"2019-12-30T11:02:44Z","timestamp":1577703764000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["CIBER-CLAP (CIBERCV Cardioprotection Large Animal Platform): A multicenter preclinical network for testing reproducibility in cardiovascular interventions"],"prefix":"10.1038","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6783-8463","authenticated-orcid":false,"given":"Xavier","family":"Rossello","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2930-8773","authenticated-orcid":false,"given":"Antonio","family":"Rodriguez-Sinovas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gemma","family":"Vilahur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ver\u00f3nica","family":"Cris\u00f3stomo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inmaculada","family":"Jorge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Zaragoza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 L.","family":"Zamorano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Bermejo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Ordo\u00f1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0253-5469","authenticated-orcid":false,"given":"Lisardo","family":"Bosc\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1461-5092","authenticated-orcid":false,"given":"Jes\u00fas","family":"V\u00e1zquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Badim\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2138-988X","authenticated-orcid":false,"given":"Francisco M.","family":"S\u00e1nchez-Margallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Fern\u00e1ndez-Avil\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Garcia-Dorado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Borja","family":"Ibanez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,12,30]]},"reference":[{"key":"56613_CR1","first-page":"774","volume":"38","author":"G Heusch","year":"2017","unstructured":"Heusch, G. & Gersh, B. J. The pathophysiology of acute myocardial infarction and strategies of protection beyond reperfusion: a continual challenge. Eur. Heart J. 38, 774\u2013784 (2017).","journal-title":"Eur. Heart J."},{"key":"56613_CR2","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1001\/jama.293.8.979","volume":"293","author":"BJ Gersh","year":"2005","unstructured":"Gersh, B. J., Stone, G. W., White, H. D. & Holmes, D. R. Pharmacological facilitation of primary percutaneous coronary intervention for acute myocardial infarction: is the slope of the curve the shape of the future? JAMA 293, 979\u2013986 (2005).","journal-title":"JAMA"},{"key":"56613_CR3","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1016\/j.jacc.2015.02.032","volume":"65","author":"B Ib\u00e1\u00f1ez","year":"2015","unstructured":"Ib\u00e1\u00f1ez, B., Heusch, G., Ovize, M. & Van de Werf, F. Evolving Therapies for Myocardial Ischemia\/Reperfusion Injury. J. Am. Coll. Cardiol. 65, 1454\u20131471 (2015).","journal-title":"J. Am. Coll. Cardiol."},{"key":"56613_CR4","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1056\/NEJMra071667","volume":"357","author":"DM Yellon","year":"2007","unstructured":"Yellon, D. M. & Hausenloy, D. J. Myocardial reperfusion injury. N. Engl. J. Med. 357, 1121\u201335 (2007).","journal-title":"N. Engl. J. Med."},{"key":"56613_CR5","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1177\/2048872619845283","volume":"8","author":"X Rossello","year":"2019","unstructured":"Rossello, X., Lobo-Gonzalez, M. & Ibanez, B. Editor\u2019s Choice- Pathophysiology and therapy of myocardial ischaemia\/reperfusion syndrome. Eur. Hear. J. Acute Cardiovasc. Care 8, 443\u2013456 (2019).","journal-title":"Eur. Hear. J. Acute Cardiovasc. Care"},{"key":"56613_CR6","first-page":"935","volume":"38","author":"DJ Hausenloy","year":"2017","unstructured":"Hausenloy, D. J. et al. Targeting reperfusion injury in patients with ST-segment elevation myocardial infarction: trials and tribulations. Eur. Heart J. 38, 935\u2013941 (2017).","journal-title":"Eur. Heart J."},{"key":"56613_CR7","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1161\/CIRCRESAHA.117.310820","volume":"120","author":"G Heusch","year":"2017","unstructured":"Heusch, G. Critical Issues for the Translation of Cardioprotection. Circ. Res. 120, 1477\u20131486 (2017).","journal-title":"Circ. Res."},{"key":"56613_CR8","doi-asserted-by":"publisher","first-page":"2510","DOI":"10.1093\/eurheartj\/ehu268","volume":"35","author":"F Van de Werf","year":"2014","unstructured":"Van de Werf, F. The history of coronary reperfusion. Eur. Heart J. 35, 2510\u20132515 (2014).","journal-title":"Eur. Heart J."},{"key":"56613_CR9","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1161\/CIRCRESAHA.118.312939","volume":"122","author":"X Rossello","year":"2018","unstructured":"Rossello, X. & Ibanez, B. Infarct Size Reduction by Targeting Ischemic Injury. Circ. Res. 122, 1041\u20131043 (2018).","journal-title":"Circ. Res."},{"key":"56613_CR10","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1093\/eurheartj\/ehx393","volume":"39","author":"B Ibanez","year":"2017","unstructured":"Ibanez, B. et al. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur. Heart J. 39, 119\u2013177 (2017).","journal-title":"Eur. Heart J."},{"key":"56613_CR11","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1161\/CIRCULATIONAHA.116.022829","volume":"134","author":"X Rossello","year":"2016","unstructured":"Rossello, X. & Yellon, D. M. Cardioprotection: The Disconnect Between Bench and Bedside. Circulation 134, 574\u2013575 (2016).","journal-title":"Circulation"},{"key":"56613_CR12","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.ijcard.2016.06.131","volume":"220","author":"X Rossello","year":"2016","unstructured":"Rossello, X. & Yellon, D. M. A critical review on the translational journey of cardioprotective therapies! Int. J. Cardiol. 220, 176\u2013184 (2016).","journal-title":"Int. J. Cardiol."},{"key":"56613_CR13","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1161\/CIRCRESAHA.116.308736","volume":"119","author":"G Heusch","year":"2016","unstructured":"Heusch, G. & Rassaf, T. Time to Give Up on Cardioprotection? A Critical Appraisal of Clinical Studies on Ischemic Pre-, Post-, and Remote Conditioning. Circ. Res. 119, 676\u2013695 (2016).","journal-title":"Circ. Res."},{"key":"56613_CR14","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1056\/NEJMoa1505489","volume":"373","author":"T-T Cung","year":"2015","unstructured":"Cung, T.-T. et al. Cyclosporine before PCI in patients with acute myocardial infarction. N. Engl. J. Med. 373, 1021\u20131031 (2015).","journal-title":"N. Engl. J. Med."},{"key":"56613_CR15","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1001\/jamacardio.2017.0022","volume":"2","author":"T Engstr\u00f8m","year":"2017","unstructured":"Engstr\u00f8m, T. et al. Effect of Ischemic Postconditioning During Primary Percutaneous Coronary Intervention for Patients With ST-Segment Elevation Myocardial Infarction. JAMA Cardiol. 2, 490 (2017).","journal-title":"JAMA Cardiol."},{"key":"56613_CR16","doi-asserted-by":"publisher","unstructured":"Hausenloy, D. J. et al. Effect of remote ischaemic conditioning on clinical outcomes in patients with acute myocardial infarction (CONDI-2\/ERIC-PPCI): a single-blind randomised controlled trial. Lancet; https:\/\/doi.org\/10.1016\/S0140-6736(19)32039-2 (2019).","DOI":"10.1016\/S0140-6736(19)32039-2"},{"key":"56613_CR17","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/nrcardio.2014.137","volume":"11","author":"V Fuster","year":"2014","unstructured":"Fuster, V. Top 10 cardiovascular therapies and interventions for the next decade. Nat. Rev. Cardiol. 11, 671\u2013683 (2014).","journal-title":"Nat. Rev. Cardiol."},{"key":"56613_CR18","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1161\/CIRCULATIONAHA.113.003653","volume":"128","author":"B Ibanez","year":"2013","unstructured":"Ibanez, B. et al. Effect of early metoprolol on infarct size in ST-segment-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: the Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction (METOCARD-CNIC). Circulation 128, 1495\u20131503 (2013).","journal-title":"Circulation"},{"key":"56613_CR19","doi-asserted-by":"publisher","first-page":"2356","DOI":"10.1016\/j.jacc.2014.03.014","volume":"63","author":"G Pizarro","year":"2014","unstructured":"Pizarro, G. et al. Long-term benefit of early pre-reperfusion metoprolol administration in patients with acute myocardial infarction: results from the METOCARD-CNIC trial (Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction). J. Am. Coll. Cardiol. 63, 2356\u20132362 (2014).","journal-title":"J. Am. Coll. Cardiol."},{"key":"56613_CR20","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/S0140-6736(09)62001-8","volume":"375","author":"HE B\u00f8tker","year":"2010","unstructured":"B\u00f8tker, H. E. et al. Remote ischaemic conditioning before hospital admission, as a complement to angioplasty, and effect on myocardial salvage in patients with acute myocardial infarction: a randomised trial. Lancet 375, 727\u2013734 (2010).","journal-title":"Lancet"},{"key":"56613_CR21","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1016\/S0140-6736(07)61634-1","volume":"370","author":"M Kitakaze","year":"2007","unstructured":"Kitakaze, M. et al. Human atrial natriuretic peptide and nicorandil as adjuncts to reperfusion treatment for acute myocardial infarction (J-WIND): two randomised trials. Lancet 370, 1483\u20131493 (2007).","journal-title":"Lancet"},{"key":"56613_CR22","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1093\/eurheartj\/ehr309","volume":"33","author":"J L\u00f8nborg","year":"2012","unstructured":"L\u00f8nborg, J. et al. Exenatide reduces reperfusion injury in patients with ST-segment elevation myocardial infarction. Eur. Heart J. 33, 1491\u20131499 (2012).","journal-title":"Eur. Heart J."},{"key":"56613_CR23","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/S0140-6736(12)60916-7","volume":"381","author":"G Heusch","year":"2013","unstructured":"Heusch, G. Cardioprotection: chances and challenges of its translation. Lancet 381, 166\u2013175 (2013).","journal-title":"Lancet"},{"key":"56613_CR24","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1161\/CIRCRESAHA.115.305841","volume":"116","author":"R Fern\u00e1ndez-Jim\u00e9nez","year":"2015","unstructured":"Fern\u00e1ndez-Jim\u00e9nez, R. & Ibanez, B. CAESAR: one step beyond in the construction of a translational bridge for cardioprotection. Circ. Res. 116, 554\u2013556 (2015).","journal-title":"Circ. Res."},{"key":"56613_CR25","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1161\/01.RES.0000137171.97172.d7","volume":"95","author":"R Bolli","year":"2004","unstructured":"Bolli, R. et al. Myocardial protection at a crossroads: the need for translation into clinical therapy. Circ. Res. 95, 125\u2013134 (2004).","journal-title":"Circ. Res."},{"key":"56613_CR26","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1161\/CIRCRESAHA.115.307496","volume":"117","author":"R Bolli","year":"2015","unstructured":"Bolli, R. Reflections on the Irreproducibility of Scientific Papers. Circ. Res. 117, 665\u2013666 (2015).","journal-title":"Circ. Res."},{"key":"56613_CR27","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s00395-018-0696-8","volume":"113","author":"HE B\u00f8tker","year":"2018","unstructured":"B\u00f8tker, H. E. et al. Practical guidelines for rigor and reproducibility in preclinical and clinical studies on cardioprotection. Basic Res. Cardiol. 113, 39 (2018).","journal-title":"Basic Res. Cardiol."},{"key":"56613_CR28","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1093\/cvr\/cvu225","volume":"104","author":"S Lecour","year":"2014","unstructured":"Lecour, S. et al. ESC working group cellular biology of the heart: position paper: improving the preclinical assessment of novel cardioprotective therapies. Cardiovasc. Res. 104, 399\u2013411 (2014).","journal-title":"Cardiovasc. Res."},{"key":"56613_CR29","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s00395-016-0558-1","volume":"111","author":"RM Bell","year":"2016","unstructured":"Bell, R. M. et al. 9th Hatter Biannual Meeting: position document on ischaemia\/reperfusion injury, conditioning and the ten commandments of cardioprotection. Basic Res. Cardiol. 111, 41 (2016).","journal-title":"Basic Res. Cardiol."},{"key":"56613_CR30","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1007\/s10557-016-6673-2","volume":"30","author":"X Rossello","year":"2016","unstructured":"Rossello, X. et al. Exogenous Administration of Recombinant MIF at Physiological Concentrations Failed to Attenuate Infarct Size in a Langendorff Perfused Isolated Mouse Heart Model. Cardiovasc. Drugs Ther. 30, 445\u2013453 (2016).","journal-title":"Cardiovasc. Drugs Ther."},{"key":"56613_CR31","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1007\/s12265-018-9819-8","volume":"11","author":"X Rossello","year":"2018","unstructured":"Rossello, X. et al. Mirabegron, a Clinically Approved \u03b23 Adrenergic Receptor Agonist, Does Not Reduce Infarct Size in a Swine Model of Reperfused Myocardial Infarction. J. Cardiovasc. Transl. Res. 11, 310\u2013318 (2018).","journal-title":"J. Cardiovasc. Transl. Res."},{"key":"56613_CR32","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s00395-017-0605-6","volume":"112","author":"JM Garc\u00eda-Ruiz","year":"2017","unstructured":"Garc\u00eda-Ruiz, J. M. et al. Bloodless reperfusion with the oxygen carrier HBOC-201 in acute myocardial infarction: a novel platform for cardioprotective probes delivery. Basic Res. Cardiol. 112, 17 (2017).","journal-title":"Basic Res. Cardiol."},{"key":"56613_CR33","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1023\/A:1007850527878","volume":"14","author":"GF Baxter","year":"2000","unstructured":"Baxter, G. F. et al. Adenosine A1 agonist at reperfusion trial (AART): results of a three-center, blinded, randomized, controlled experimental infarct study. Cardiovasc. drugs Ther. 14, 607\u2013614 (2000).","journal-title":"Cardiovasc. drugs Ther."},{"key":"56613_CR34","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1161\/CIRCRESAHA.116.305462","volume":"116","author":"SP Jones","year":"2015","unstructured":"Jones, S. P. et al. The NHLBI-sponsored Consortium for preclinicAl assESsment of cARdioprotective therapies (CAESAR): a new paradigm for rigorous, accurate, and reproducible evaluation of putative infarct-sparing interventions in mice, rabbits, and pigs. Circ. Res. 116, 572\u2013586 (2015).","journal-title":"Circ. Res."},{"key":"56613_CR35","doi-asserted-by":"publisher","first-page":"e1000412","DOI":"10.1371\/journal.pbio.1000412","volume":"8","author":"C Kilkenny","year":"2010","unstructured":"Kilkenny, C., Browne, W. J., Cuthill, I. C., Emerson, M. & Altman, D. G. Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research. PLoS Biol. 8, e1000412 (2010).","journal-title":"PLoS Biol."},{"key":"56613_CR36","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1124\/pr.107.06002","volume":"59","author":"P Ferdinandy","year":"2007","unstructured":"Ferdinandy, P., Schulz, R. & Baxter, G. F. Interaction of cardiovascular risk factors with myocardial ischemia\/reperfusion injury, preconditioning, and postconditioning. Pharmacol. Rev. 59, 418\u2013458 (2007).","journal-title":"Pharmacol. Rev."},{"key":"56613_CR37","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1161\/01.CIR.74.5.1124","volume":"74","author":"CE Murry","year":"1986","unstructured":"Murry, C. E., Jennings, R. B. & Reimer, K. A. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 74, 1124\u20131136 (1986).","journal-title":"Circulation"},{"key":"56613_CR38","doi-asserted-by":"publisher","first-page":"e0142021","DOI":"10.1371\/journal.pone.0142021","volume":"10","author":"KE Wever","year":"2015","unstructured":"Wever, K. E. et al. Determinants of the Efficacy of Cardiac Ischemic Preconditioning: A Systematic Review and Meta-Analysis of Animal Studies. PLoS One 10, e0142021 (2015).","journal-title":"PLoS One"},{"key":"56613_CR39","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1007\/s00395-016-0588-8","volume":"111","author":"DJ Hausenloy","year":"2016","unstructured":"Hausenloy, D. J. et al. Ischaemic conditioning and targeting reperfusion injury: a 30 year voyage of discovery. Basic Res. Cardiol. 111, 70 (2016).","journal-title":"Basic Res. Cardiol."},{"key":"56613_CR40","doi-asserted-by":"publisher","first-page":"e32296","DOI":"10.1371\/journal.pone.0032296","volume":"7","author":"KE Wever","year":"2012","unstructured":"Wever, K. E. et al. Ischemic Preconditioning in the Animal Kidney, a Systematic Review and Meta-Analysis. PLoS One 7, e32296 (2012).","journal-title":"PLoS One"},{"key":"56613_CR41","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/0140-6736(93)91819-8","volume":"342","author":"DM Yellon","year":"1993","unstructured":"Yellon, D. M., Alkhulaifi, A. M. & Pugsley, W. B. Preconditioning the human myocardium. Lancet 342, 276\u2013277 (1993).","journal-title":"Lancet"},{"key":"56613_CR42","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1007\/BF00788520","volume":"92","author":"CS Carr","year":"1997","unstructured":"Carr, C. S. & Yellon, D. M. Ischaemic preconditioning may abolish the protection afforded by ATP-sensitive potassium channel openers in isolated human atrial muscle. Basic Res. Cardiol. 92, 252\u2013260 (1997).","journal-title":"Basic Res. Cardiol."},{"key":"56613_CR43","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/nrcardio.2016.5","volume":"13","author":"DJ Hausenloy","year":"2016","unstructured":"Hausenloy, D. J. & Yellon, D. M. Ischaemic conditioning and reperfusion injury. Nat. Rev. Cardiol. 13, 193\u2013209 (2016).","journal-title":"Nat. Rev. Cardiol."},{"key":"56613_CR44","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1161\/01.CIR.98.10.1022","volume":"98","author":"R Schulz","year":"1998","unstructured":"Schulz, R., Post, H., Vahlhaus, C. & Heusch, G. Ischemic preconditioning in pigs: a graded phenomenon: its relation to adenosine and bradykinin. Circulation 98, 1022\u20131029 (1998).","journal-title":"Circulation"},{"key":"56613_CR45","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1161\/01.CIR.87.3.893","volume":"87","author":"K Przyklenk","year":"1993","unstructured":"Przyklenk, K., Bauer, B., Ovize, M., Kloner, R. A. & Whittaker, P. Regional ischemic \u2018preconditioning\u2019 protects remote virgin myocardium from subsequent sustained coronary occlusion. Circulation 87, 893\u2013899 (1993).","journal-title":"Circulation"},{"key":"56613_CR46","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1136\/hrt.2006.114504","volume":"93","author":"G Andreka","year":"2007","unstructured":"Andreka, G. et al. Remote ischaemic postconditioning protects the heart during acute myocardial infarction in pigs. Heart 93, 749\u2013752 (2007).","journal-title":"Heart"},{"key":"56613_CR47","doi-asserted-by":"publisher","first-page":"3049","DOI":"10.1093\/eurheartj\/ehv463","volume":"36","author":"I Eitel","year":"2015","unstructured":"Eitel, I. et al. Cardioprotection by combined intrahospital remote ischaemic perconditioning and postconditioning in ST-elevation myocardial infarction: the randomized LIPSIA CONDITIONING trial. Eur. Heart J. 36, 3049\u20133057 (2015).","journal-title":"Eur. Heart J."},{"key":"56613_CR48","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1007\/s00395-017-0662-x","volume":"113","author":"X Rossello","year":"2018","unstructured":"Rossello, X. & Yellon, D. M. The RISK pathway and beyond. Basic Res. Cardiol. 113, 2 (2018).","journal-title":"Basic Res. Cardiol."},{"key":"56613_CR49","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1111\/jcmm.13394","volume":"22","author":"X Rossello","year":"2017","unstructured":"Rossello, X., Riquelme, J. A., Davidson, S. M. & Yellon, D. M. Role of PI3K in myocardial ischaemic preconditioning: mapping pro-survival cascades at the trigger phase and at reperfusion. J. Cell. Mol. Med. 22, 926\u2013935 (2017).","journal-title":"J. Cell. Mol. Med."},{"key":"56613_CR50","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1161\/CIRCRESAHA.116.305348","volume":"116","author":"G Heusch","year":"2015","unstructured":"Heusch, G. Molecular basis of cardioprotection: signal transduction in ischemic pre-, post-, and remote conditioning. Circ. Res. 116, 674\u2013699 (2015).","journal-title":"Circ. Res."},{"key":"56613_CR51","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1016\/j.jacc.2016.02.050","volume":"67","author":"JM Garc\u00eda-Ruiz","year":"2016","unstructured":"Garc\u00eda-Ruiz, J. M. et al. Impact of the Timing of Metoprolol Administration During STEMI on Infarct Size and Ventricular Function. J. Am. Coll. Cardiol. 67, 2093\u20132104 (2016).","journal-title":"J. Am. Coll. Cardiol."},{"key":"56613_CR52","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1136\/heartjnl-2015-308980","volume":"102","author":"K Pryds","year":"2016","unstructured":"Pryds, K. et al. Remote ischaemic conditioning and healthcare system delay in patients with ST-segment elevation myocardial infarction. Heart 102, 1023\u20131028 (2016).","journal-title":"Heart"},{"key":"56613_CR53","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1007\/s00395-017-0657-7","volume":"112","author":"X Rossello","year":"2017","unstructured":"Rossello, X. et al. The role of PI3K\u03b1 isoform in cardioprotection. Basic Res. Cardiol. 112, 66 (2017).","journal-title":"Basic Res. Cardiol."},{"key":"56613_CR54","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s10557-018-6788-8","volume":"32","author":"X Rossello","year":"2018","unstructured":"Rossello, X., He, Z. & Yellon, D. M. Myocardial Infarct Size Reduction Provided by Local and Remote Ischaemic Preconditioning: References Values from the Hatter Cardiovascular Institute. Cardiovasc. Drugs Ther. 32, 127\u2013133 (2018).","journal-title":"Cardiovasc. Drugs Ther."},{"key":"56613_CR55","doi-asserted-by":"publisher","first-page":"H478","DOI":"10.1152\/ajpheart.00749.2016","volume":"312","author":"S Gent","year":"2017","unstructured":"Gent, S., Skyschally, A., Kleinbongard, P. & Heusch, G. lschemic preconditioning in pigs: a causal role for signal transducer and activator of transcription 3. Am. J. Physiol. Heart Circ. Physiol. 312, H478\u2013H484 (2017).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"56613_CR56","doi-asserted-by":"publisher","first-page":"H812","DOI":"10.1152\/ajpheart.00335.2017","volume":"314","author":"ML Lindsey","year":"2018","unstructured":"Lindsey, M. L. et al. Guidelines for experimental models of myocardial ischemia and infarction. American Journal of Physiology - Heart and Circulatory Physiology 314, H812\u2013H838 (2018).","journal-title":"American Journal of Physiology - Heart and Circulatory Physiology"},{"key":"56613_CR57","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/j.yjmcc.2011.02.016","volume":"50","author":"G Heusch","year":"2011","unstructured":"Heusch, G., Skyschally, A. & Schulz, R. The in-situ pig heart with regional ischemia\/reperfusion - ready for translation. J. Mol. Cell. Cardiol. 50, 951\u2013963 (2011).","journal-title":"J. Mol. Cell. Cardiol."},{"key":"56613_CR58","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.jacc.2014.11.004","volume":"65","author":"R Fern\u00e1ndez-Jim\u00e9nez","year":"2015","unstructured":"Fern\u00e1ndez-Jim\u00e9nez, R. et al. Myocardial Edema After Ischemia\/Reperfusion Is Not Stable and Follows a Bimodal Pattern. J. Am. Coll. Cardiol. 65, 315\u2013323 (2015).","journal-title":"J. Am. Coll. Cardiol."},{"key":"56613_CR59","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1161\/CIRCRESAHA.117.310901","volume":"121","author":"R Fern\u00e1ndez-Jim\u00e9nez","year":"2017","unstructured":"Fern\u00e1ndez-Jim\u00e9nez, R. et al. Effect of Ischemia Duration and Protective Interventions on the Temporal Dynamics of Tissue Composition After Myocardial Infarction. Circ. Res. 121, 439\u2013450 (2017).","journal-title":"Circ. Res."},{"key":"56613_CR60","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.jss.2014.01.016","volume":"188","author":"K Yamakawa","year":"2014","unstructured":"Yamakawa, K. et al. Improved cardioprotection using a novel stepwise ischemic preconditioning protocol in rabbit heart. J. Surg. Res. 188, 381\u2013386 (2014).","journal-title":"J. Surg. Res."},{"key":"56613_CR61","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1006\/jmcc.1996.0328","volume":"29","author":"EK Iliodromitis","year":"1997","unstructured":"Iliodromitis, E. K., Kremastinos, D. T., Katritsis, D. G., Papadopoulos, C. C. & Hearse, D. J. Multiple cycles of preconditioning cause loss of protection in open-chest rabbits. J. Mol. Cell. Cardiol. 29, 915\u2013920 (1997).","journal-title":"J. Mol. Cell. Cardiol."},{"key":"56613_CR62","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/j.jacc.2015.06.023","volume":"66","author":"R Fern\u00e1ndez-Jim\u00e9nez","year":"2015","unstructured":"Fern\u00e1ndez-Jim\u00e9nez, R. et al. Pathophysiology Underlying the Bimodal Edema Phenomenon After Myocardial Ischemia\/Reperfusion. J. Am. Coll. Cardiol. 66, 816\u2013828 (2015).","journal-title":"J. Am. Coll. Cardiol."},{"key":"56613_CR63","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1161\/CIRCULATIONAHA.116.025582","volume":"136","author":"R Fern\u00e1ndez-Jim\u00e9nez","year":"2017","unstructured":"Fern\u00e1ndez-Jim\u00e9nez, R. et al. Dynamic Edematous Response of the Human Heart to Myocardial Infarction: Implications for Assessing Myocardial Area at Risk and Salvage. Circulation 136, 1288\u20131300 (2017).","journal-title":"Circulation"},{"key":"56613_CR64","doi-asserted-by":"publisher","first-page":"927","DOI":"10.2527\/jas1973.365927x","volume":"36","author":"KW Kelley","year":"1973","unstructured":"Kelley, K. W., Curtis, S. E., Marzan, G. T., Karara, H. M. & Anderson, C. R. Body surface area of female swine. J. Anim. Sci. 36, 927\u2013930 (1973).","journal-title":"J. Anim. Sci."},{"key":"56613_CR65","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.recesp.2016.07.005","volume":"70","author":"L Fern\u00e1ndez-Friera","year":"2017","unstructured":"Fern\u00e1ndez-Friera, L. et al. Accuracy of Area at Risk Quantification by Cardiac Magnetic Resonance According to the Myocardial Infarction Territory. Rev. Espa\u00f1ola Cardiol. 70, 323\u2013330 (2017).","journal-title":"Rev. Espa\u00f1ola Cardiol."},{"key":"56613_CR66","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1177\/1074248415604462","volume":"21","author":"X Rossello","year":"2015","unstructured":"Rossello, X., Hall, A. R., Bell, R. M. & Yellon, D. M. Characterization of the Langendorff Perfused Isolated Mouse Heart Model of Global Ischemia-Reperfusion Injury: Impact of Ischemia and Reperfusion Length on Infarct Size and LDH Release. J. Cardiovasc. Pharmacol. Ther. 21, 286\u2013295 (2015).","journal-title":"J. Cardiovasc. Pharmacol. Ther."},{"key":"56613_CR67","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-11985-5","volume":"7","author":"A Binek","year":"2017","unstructured":"Binek, A. et al. Proteomic footprint of myocardial ischemia\/reperfusion injury: Longitudinal study of the at-risk and remote regions in the pig model. Sci. Rep. 7, 12343 (2017).","journal-title":"Sci. Rep."},{"key":"56613_CR68","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1074\/mcp.M700239-MCP200","volume":"7","author":"S Mart\u00ednez-Bartolom\u00e9","year":"2008","unstructured":"Mart\u00ednez-Bartolom\u00e9, S. et al. Properties of average score distributions of SEQUEST: the probability ratio method. Mol. Cell. Proteomics 7, 1135\u20131145 (2008).","journal-title":"Mol. Cell. Proteomics"},{"key":"56613_CR69","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1021\/pr800362h","volume":"8","author":"P Navarro","year":"2009","unstructured":"Navarro, P. & V\u00e1zquez, J. A refined method to calculate false discovery rates for peptide identification using decoy databases. J. Proteome Res. 8, 1792\u20131796 (2009).","journal-title":"J. Proteome Res."},{"key":"56613_CR70","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1021\/pr5007284","volume":"14","author":"E Bonzon-Kulichenko","year":"2015","unstructured":"Bonzon-Kulichenko, E., Garcia-Marques, F., Trevisan-Herraz, M. & V\u00e1zquez, J. Revisiting peptide identification by high-accuracy mass spectrometry: problems associated with the use of narrow mass precursor windows. J. Proteome Res. 14, 700\u2013710 (2015).","journal-title":"J. Proteome Res."},{"key":"56613_CR71","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1021\/pr4006958","volume":"13","author":"P Navarro","year":"2014","unstructured":"Navarro, P. et al. General statistical framework for quantitative proteomics by stable isotope labeling. J. Proteome Res. 13, 1234\u20131247 (2014).","journal-title":"J. Proteome Res."},{"key":"56613_CR72","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1074\/mcp.M115.055905","volume":"15","author":"F Garc\u00eda-Marqu\u00e9s","year":"2016","unstructured":"Garc\u00eda-Marqu\u00e9s, F. et al. A Novel Systems-Biology Algorithm for the Analysis of Coordinated Protein Responses Using Quantitative Proteomics. Mol. Cell. Proteomics 15, 1740\u20131760 (2016).","journal-title":"Mol. Cell. Proteomics"},{"key":"56613_CR73","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1093\/bioinformatics\/bty815","volume":"35","author":"M Trevisan-Herraz","year":"2018","unstructured":"Trevisan-Herraz, M. et al. SanXoT: a modular and versatile package for the quantitative analysis of high-throughput proteomics experiments. Bioinformatics 35, 1594\u20131596 (2018).","journal-title":"Bioinformatics"},{"key":"56613_CR74","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1074\/mcp.M111.016469","volume":"11","author":"P Mart\u00ednez-Acedo","year":"2012","unstructured":"Mart\u00ednez-Acedo, P. et al. A novel strategy for global analysis of the dynamic thiol redox proteome. Mol. Cell. Proteomics 11, 800\u2013813 (2012).","journal-title":"Mol. Cell. Proteomics"},{"key":"56613_CR75","first-page":"288","volume":"113","author":"DI Bromage","year":"2016","unstructured":"Bromage, D. I. et al. Remote ischaemic conditioning reduces infarct size in animal in vivo models of ischaemia-reperfusion injury: a systematic review and meta-analysis. Cardiovasc. Res. 113, 288\u2013297 (2016).","journal-title":"Cardiovasc. Res."},{"key":"56613_CR76","doi-asserted-by":"publisher","first-page":"3393","DOI":"10.1093\/eurheartj\/ehy253","volume":"39","author":"G Heusch","year":"2018","unstructured":"Heusch, G. Cardioprotection research must leave its comfort zone. Eur. Heart J. 39, 3393\u20133395 (2018).","journal-title":"Eur. Heart J."},{"key":"56613_CR77","first-page":"116","volume":"1","author":"I Andreadou","year":"2018","unstructured":"Andreadou, I. et al. Realizing the therapeutic potential of novel cardioprotective therapies: The EU-CARDIOPROTECTION COST Action -CA16225. Cond. Med. 1, 116\u2013123 (2018).","journal-title":"Cond. Med."},{"key":"56613_CR78","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1111\/bph.12903","volume":"172","author":"MV Cohen","year":"2015","unstructured":"Cohen, M. V. & Downey, J. M. Signalling pathways and mechanisms of protection in pre- and postconditioning: historical perspective and lessons for the future. Br. J. Pharmacol. 172, 1913\u20131932 (2015).","journal-title":"Br. J. Pharmacol."},{"key":"56613_CR79","doi-asserted-by":"publisher","first-page":"H1481","DOI":"10.1152\/ajpheart.01089.2001","volume":"283","author":"D Schulman","year":"2002","unstructured":"Schulman, D., Latchman, D. S. & Yellon, D. M. Urocortin protects the heart from reperfusion injury via upregulation of p42\/p44 MAPK signaling pathway. Am. J. Physiol. Hear. Circ. Physiol. 283, H1481\u2013H1488 (2002).","journal-title":"Am. J. Physiol. Hear. Circ. Physiol."},{"key":"56613_CR80","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s10741-007-9026-1","volume":"12","author":"DJ Hausenloy","year":"2007","unstructured":"Hausenloy, D. J. & Yellon, D. M. Reperfusion injury salvage kinase signalling: taking a RISK for cardioprotection. Heart Fail. Rev. 12, 217\u2013234 (2007).","journal-title":"Heart Fail. Rev."},{"key":"56613_CR81","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s00395-017-0660-z","volume":"113","author":"P Kleinbongard","year":"2018","unstructured":"Kleinbongard, P., Skyschally, A., Gent, S., Pesch, M. & Heusch, G. STAT3 as a common signal of ischemic conditioning: a lesson on \u201crigor and reproducibility\u201d in preclinical studies on cardioprotection. Basic Res. Cardiol. 113, 3 (2018).","journal-title":"Basic Res. Cardiol."},{"key":"56613_CR82","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.yjmcc.2009.01.003","volume":"46","author":"S Lecour","year":"2009","unstructured":"Lecour, S. Multiple protective pathways against reperfusion injury: a SAFE path without Aktion? J. Mol. Cell. Cardiol. 46, 607\u2013609 (2009).","journal-title":"J. Mol. Cell. Cardiol."},{"key":"56613_CR83","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1038\/sj.bjp.0707453","volume":"152","author":"MV Cohen","year":"2007","unstructured":"Cohen, M. V. & Downey, J. M. Cardioprotection: spotlight on PKG. Br. J. Pharmacol. 152, 833\u2013834 (2007).","journal-title":"Br. J. Pharmacol."},{"key":"56613_CR84","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/S0022-2828(02)00310-3","volume":"35","author":"RM Bell","year":"2003","unstructured":"Bell, R. M. & Yellon, D. M. Bradykinin limits infarction when administered as an adjunct to reperfusion in mouse heart: the role of PI3K, Akt and eNOS. J. Mol. Cell. Cardiol. 35, 185\u2013193 (2003).","journal-title":"J. Mol. Cell. Cardiol."},{"key":"56613_CR85","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/S0735-1097(02)02816-4","volume":"41","author":"RM Bell","year":"2003","unstructured":"Bell, R. M. & Yellon, D. M. Atorvastatin, administered at the onset of reperfusion, and independent of lipid lowering, protects the myocardium by up-regulating a pro-survival pathway. J. Am. Coll. Cardiol. 41, 508\u2013515 (2003).","journal-title":"J. Am. Coll. Cardiol."},{"key":"56613_CR86","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.tcm.2005.03.001","volume":"15","author":"DJ Hausenloy","year":"2005","unstructured":"Hausenloy, D. J., Tsang, A. & Yellon, D. M. The Reperfusion Injury Salvage Kinase Pathway: A Common Target for Both Ischemic Preconditioning and Postconditioning. Trends Cardiovasc. Med. 15, 69\u201375 (2005).","journal-title":"Trends Cardiovasc. Med."},{"key":"56613_CR87","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1136\/heartjnl-2013-304187","volume":"100","author":"RP Williams","year":"2014","unstructured":"Williams, R. P., Manou-Stathopoulou, V., Redwood, S. R. & Marber, M. S. \u2018Warm-up Angina\u2019: harnessing the benefits of exercise and myocardial ischaemia. Heart 100, 106\u2013114 (2014).","journal-title":"Heart"},{"key":"56613_CR88","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1093\/eurheartj\/ehu286","volume":"35","author":"E Herrett","year":"2014","unstructured":"Herrett, E. et al. Association between clinical presentations before myocardial infarction and coronary mortality: a prospective population-based study using linked electronic records. Eur. Heart J. 35, 2363\u20132371 (2014).","journal-title":"Eur. Heart J."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-56613-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-56613-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-56613-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,29]],"date-time":"2024-07-29T09:37:56Z","timestamp":1722245876000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-56613-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,30]]},"references-count":88,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["56613"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-56613-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,30]]},"assertion":[{"value":"8 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"20290"}}